GENE ONLINE|News &
Opinion
Blog

2018-03-06| Asia-PacificIPO

China’s Tasly, TCM Pharma, Plans to List in $1 Billion Hong Kong IPO

by GeneOnline
Share To

China’s Tasly Pharmaceutical Group, a traditional Chinese medicine pharmaceutical company, plans to list its biopharma unit in Hong Kong to raise about $1 billion.

By Joanne Shih

As Hong Kong Exchanges and Clearing (HKEX), the stock exchange operator of the city, is easing up its listing rules to attract early-stage drug developers, this Tianjin-based pharmaceutical company, Tasly, announced to aim at Hong Kong IPO and to list its biopharma branch, Shanghai Tasly Pharmaceutical, in the second half of 2018.

Tasly Pharmaceutical International was incorporated in 1994, and has opened overseas branches and representative offices in 21 nations or regions and 4 chain traditional Chinese medicine clinics in 4 countries after more than ten years of operation. Tasly Holding Group currently has 50-odd branches and subsidiaries and 15,000 employees, and has registered more than 50 products in over 40 countries as adjuvant, health product and functional food, according to its website. On the other hand, Shanghai Tasly was founded in 2001 in China, and the company lunched one drug for treating blood-clot induced heart attacks in 2012.

Sources from Tasly Pharmaceutical Group also indicated that the Shanghai Tasly is considering a pre-IPO fundraising, although the scale has not been confirmed yet. Nonetheless, the people with knowledge of this matter declined to release further details as they claimed that they were not authorized to speak with the media.

Reference
https://www.taslyint.com/index.php
https://www.reuters.com/article/us-tasly-pharma-hongkong-ipo/chinas-tasly-to-list-biotech-arm-in-1-billion-hong-kong-ipo-sources-idUSKBN1GH0JI

Image Source
https://www.reuters.com/article/us-tasly-pharma-hongkong-ipo/chinas-tasly-to-list-biotech-arm-in-1-billion-hong-kong-ipo-sources-idUSKBN1GH0JI

 

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
BIO CHINA 2024 Brings Biotech Experts and Industry Elites Together for Innovation
2024-03-27
Major U.S. Organization BIO Severs Ties With Member WuXi AppTec Amid U.S. Government’s Security Concerns
2024-03-15
GeneOnline’s Weekly News Highlights: Nov 13-Nov 17
2023-11-20
LATEST
Preventive Medicine for Neurodegeneration on the Rise: New Breakthrough in Routine Blood Testing for Alzheimer’s Disease
2024-05-20
Discrimination Leads to Rapid Aging, Science Shows the Detrimental Effects of this Act
2024-05-17
A New Study has Linked Treatment Resistant Depression to Body Mass Index
2024-05-16
AI Reveals Sex-Related Brain Differences and Precision Medicine Potential
2024-05-16
The EU Sustainability Directive’s Influence on Pharmaceutical Supply Chains
2024-05-15
New UC Berkeley Study Challenges Traditional Views on Lactate and Carbohydrate Metabolism
2024-05-15
First Person to Receive Transplanted Pig Kidney has Died
2024-05-13
EVENT
Scroll to Top